BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22133902)

  • 1. Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors.
    He Y; Zeng LF; Yu ZH; He R; Liu S; Zhang ZY
    Bioorg Med Chem; 2012 Mar; 20(6):1940-6. PubMed ID: 22133902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
    Zhang ZY
    Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold.
    He Y; Xu J; Yu ZH; Gunawan AM; Wu L; Wang L; Zhang ZY
    J Med Chem; 2013 Feb; 56(3):832-42. PubMed ID: 23305444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
    Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
    J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
    Zhang ZY
    Annu Rev Pharmacol Toxicol; 2002; 42():209-34. PubMed ID: 11807171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatases as potential therapeutic targets.
    He RJ; Yu ZH; Zhang RY; Zhang ZY
    Acta Pharmacol Sin; 2014 Oct; 35(10):1227-46. PubMed ID: 25220640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase beta.
    Zeng LF; Zhang RY; Bai Y; Wu L; Gunawan AM; Zhang ZY
    Antioxid Redox Signal; 2014 May; 20(14):2130-40. PubMed ID: 24180557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Druggable targets of protein tyrosine phosphatase Family, viz. PTP1B, SHP2, Cdc25, and LMW-PTP: Current scenario on medicinal Attributes, and SAR insights.
    Bhavana ; Kohal R; Kumari P; Das Gupta G; Kumar Verma S
    Bioorg Chem; 2024 Mar; 144():107121. PubMed ID: 38237392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
    Malamas MS; Sredy J; Moxham C; Katz A; Xu W; McDevitt R; Adebayo FO; Sawicki DR; Seestaller L; Sullivan D; Taylor JR
    J Med Chem; 2000 Apr; 43(7):1293-310. PubMed ID: 10753467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies of protein tyrosine phosphatases with chemical approaches.
    Zhang ZY
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B.
    Lee S; Wang Q
    Med Res Rev; 2007 Jul; 27(4):553-73. PubMed ID: 17039461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
    He R; Zeng LF; He Y; Zhang S; Zhang ZY
    FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
    Krabill AD; Zhang ZY
    Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis.
    Adams J; Thornton BP; Tabernero L
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Druggability analysis and classification of protein tyrosine phosphatase active sites.
    Ghattas MA; Raslan N; Sadeq A; Al Sorkhy M; Atatreh N
    Drug Des Devel Ther; 2016; 10():3197-3209. PubMed ID: 27757011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery and protein tyrosine phosphatases.
    Blaskovich MA
    Curr Med Chem; 2009; 16(17):2095-176. PubMed ID: 19519384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
    Chen L; Sung SS; Yip ML; Lawrence HR; Ren Y; Guida WC; Sebti SM; Lawrence NJ; Wu J
    Mol Pharmacol; 2006 Aug; 70(2):562-70. PubMed ID: 16717135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
    Barr AJ; Knapp S
    Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.